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Down Syndrome is the most common congenital cause of developmental disability in Ireland with a birth prevalence of 1 in 546 live births, which is the highest in Europe. It is well recognised that as a group they have a high incidence of treatable medical disorders. All studies show that early intervention carries a better outcome for their general health, quality of life and life expectancy. With medical progress many now live into their sixties.
In order to assess the medical and psychosocial needs of children and adolescents with Down syndrome in Ireland we conducted a surveillance study in the Eastern Health Board (now the Eastern Regional Health Authority).
Medical guidelines were originally developed by the Down Syndrome Medical Interest Group for use in the United Kingdom. Our research provided the necessary evidence based data to construct medical management guidelines appropriate for children and adolescents with Down syndrome in Ireland. Implementation of these guidelines is now urgently required.
We are very grateful to Dr. Jennifer Dennis, Director of Information and Research, DSMIG, Dr. Liz Marder, Vice Chairman DSMIG and all members of the group for the enormous amount of work that they have undertaken in the development of the guidelines.
We are also very grateful to the many Irish health professionals who supported and assisted us in carrying out the study and in particular we wish to express our sincere thanks to all the parents and children who took part in the study. 17 . Allen DB, Frasier SD, Foley TP Jr., Pescovitz OH (1993). Growth hormone for children with Down's syndrome (editorial). J of Pediatrics, 123:742-3.
18. Anneren G, Gustafsson J, Sara VR, Tuvemo T (1993). Normalised growth velocity in children with Down's syndrome during growth hormone therapy. J of Intell Disability Res 37(4): 381-7.
19. 
FOR PEOPLE WITH DOWN SYNDROME

CARDIAC DISEASE
CONGENITAL AND ACQUIRED
1.
Between 40 and 50% of babies with Down syndrome have congenital heart defects. Of these 30-40% have complete atrioventricular septal defects (AVSD).
1,2
Most AVSD can be successfully treated if the diagnosis is made and the baby referred for full corrective surgery before irreversible pulmonary vascular disease is established. 3 2. There must be a high level of clinical suspicion of congenital heart disease for all newborns with the syndrome
3.
It is essential to establish the cardiac status of every child by age 6 weeks. [4] [5] [6] [7] [8] [9] [10] 4. Clinical examination alone is insufficient to detect even some of the most serious abnormalities.
2,8,11
5.
It is very unlikely that a serious abnormality requiring early intervention (AVSD) will be missed if one of the following courses of action is taken. 2, 10, 12 (a) Clinical examination plus electrocardiogram (ECG) and chest X-ray (CXR) for all newborns and again at age 6 weeks, followed by echocardiography only for those with abnormal findings. or (b) Clinical examination, ECG plus echocardiogram in the newborn period, both carried out by an appropriate person (see below 6).
However, even if early investigations are reported as 'normal', if a child develops signs or symptoms of cardiac disease appropriate investigations must take place, as structural problems may not have been evident at an earlier age. 
7.
It is recognised that minor heart defects (atrial septal defect and small ventricular septal defects) may be missed in those children who do not have echocardiograms but these should declare themselves clinically, as for any child, in the normal course of child health surveillance.
8. Parents and carers of all children with Down syndrome with heart lesions should be given verbal and written information about infective carditis preventive measures.
9. It should be remembered that despite a normal echo at birth children with Down syndrome, like all other children, can develop symptoms and signs of heart disease at a later age e.g. secondary to airway problems. 13 10. There is an increased incidence of mitral valve prolapse and of aortic regurgitation in adults. This has implications for infective carditis prevention particularly because of the high incidence of periodontal disease among this population. We therefore recommend an echo screen for all people with Down's syndrome early in adult life. 
BASIC MEDICAL SURVEILLANCE ESSENTIALS FOR PEOPLE WITH DOWN SYNDROME
THYROID DISORDER
1. At all ages thyroid disorder (usually hypothyroidism) occurs more frequently in people with Down syndrome than in the general population. [1] [2] [3] [4] [5] Around 10% of the school age population have uncompensated hypothyroidism. The prevalence increases with age. 6 If undiagnosed, thyroid disorder constitutes a significant cause of preventable secondary handicap. Diagnosis on clinical grounds is unreliable. 7, 8 Biochemical screening is essential. As in the general population those with significant abnormalities of any thyroid function test (TFT) should either be treated (if there is uncompensated hypothyroidism) or kept under close clinical and biochemical surveillance.
2. All babies in the U.K and Ireland have a neonatal screen for hypothyroidism. 9 3. Biochemical testing, including estimation of T4, TSH, and thyroid antibodies should be carried out at least once every two years from age 1 year and throughout life. 6, 10 4. Information is currently coming in from several areas where the feasibility of fingerprick TSH Guthrie screening is being investigated. Preliminary evaluation suggests that this may prove an effective screening procedure, which may be possible annually, once the appropriate structures, personnel and funding are in place.
5. Transient changes may occur. 10, 11 Mildly raised TSH (5-10mU/l) or the presence of antibodies with normal T4 and no clinical evidence of hypothyroidism may not warrant treatment. 12, 13 It does however indicate increased likelihood of developing uncompensated hypothyroidism. Such people should therefore be tested more frequently than those with normal test results. A specialist opinion may be required.
6. Clinicians should always bear in mind the high prevalence of thyroid disorder in people with Down syndrome and have a low threshold for testing thyroid function if there is any clinical suspicion at times between biochemical testing.
7. As in the general population key clinical pointers are lethargy and/or changes in affect, cognition, growth, or weight.
8. Consideration of hypothyroidism is mandatory in the differential diagnosis of depression and dementia.
14,15 9 . The possibility of hyperthyroidism should also be born in mind. 1. There is a high prevalence of ocular disorder among people with Down syndrome. Refractive errors and strabismus (squint) may occur at an early age and persist into childhood 1,2,3,4,5 . Over 54% of children with Down syndrome will require glasses in primary school 1 . The majority of children with Down syndrome have reduced accommodation at near (this means that they do not focus accurately on near targets), 2, 6, 7 . Cataract and/or Glaucoma may occur in infancy 8 . Cataract extraction in our population of children with Down Syndrome is a safe and effective procedure with a very encouraging visual outcome 9 . Nystagmus is present in 18% 10 and Brushfield Spots are present in the eye in many children at birth. Keratoconus 11 and cataract may develop in adolescents and young adults 12 . Untreated disorders which cause vision problems are a significant cause of preventable secondary handicap and require increased observation at all ages 5 .
2. All newborns with Down syndrome should have an eye examination carried out at 4-6 weeks to exclude congenital glaucoma, cataract and other eye abnormalities 13 and thereafter should be included in community screening programmes. Those with deviation from normal should be kept under appropriate specialist review.
5. Refractive errors, most commonly hypermetropia (long-sightedness), which often reduce spontaneously in other children, are likely to persist beyond infancy in children with Down syndrome 6,2. Correction for hypermetropia may be helpful at a younger age than that for typically developing children especially since the majority will have defective accommodation 15 2,6, 7. Distance and near functioning visual acuity and accommodative ability should be checked at every review and a prescription for near correction or bifocals considered for all children of school going age 16,2. 6. A further formal ophthalmological examination should be performed at around 4 years of age, 17,13. At this age at least 50% are likely to have refractive errors 1 .
7. After the age of 4 years vision and refractive error should be checked at least every 2 years throughout life by professionals (optometrists or ophthalmologists & orthoptists) with appropriate skills and expertise in managing this client group 18 . If hypermetropia is not present at age 4 years it is not likely to occur later on, but myopia may develop at any age 3,2 .
8. Children and adults with Down syndrome should be expected to respond to standard vision testing procedures at appropriate developmental age but a distraction free environment and extra time may be necessary to optimise performance. Others may require more specialized visual tests. Distance and near functioning visual acuity and accommodation (focussing ability) should be checked at every review. Detail vision (i.e. visual acuity ) is likely to remain poorer than expected throughout life even when appropriate spectacles are worn 19, 20 .
9. Blepharitis, (inflammation of the eyelids with redness at the edge of the lids and crusting around the lashes) has been reported to occur in up to 30% of children with Down syndrome 10, 21 and can be managed in the usual way 22 . Nasolacrimal duct obstruction also occurs commonly 21, 23 and may need specialist referral 10. Local optometrists give an excellent service but subjects who are difficult to examine in this setting should be referred to a specialist clinic.
11. As with all children, if at any age visual acuity deteriorates a specialist opinion is required.
12. Any child or adult with pain, and/or changing vision, visual disturbance and/or red eye, should be referred for urgent specialist opinion. 
HEARING IMPAIRMENT
1.
Well over 50% of people with Down syndrome have significant hearing impairment, which may be mild, moderate, severe or profound (30 ->95 dB HL). [1] [2] [3] Sensorineural and/or conductive loss may be present at any age. [3] [4] [5] [6] [7] [8] [9] [10] Hearing impairment can be successfully managed in this population. [11] [12] [13] [14] [15] If undetected it is likely to be a significant cause of preventable secondary handicap. 3, 6, 12, 14 Lifelong audiological surveillance is essential for all. [16] [17] [18] [19] [20] [21] The main cause of conductive loss is persistent otitis media with effusion (OME, glue ear). The natural history of OME and response to intervention differ from that in the general population hence local surveillance and management protocols need to be set up specific to people with Down's syndrome. 4, 6, 13, 15, 22 2.
People with Down syndrome of all ages should have rapid access to specialist audiology services. 4 3.
Because of an increased incidence of congenital sensorineural loss newborns with Down syndrome should be included in neonatal screening programmes where available. 1, 14, 19 This does not preclude the need for ongoing surveillance. 16 
4.
Guidance for parents of children with Down syndrome should include discussion about hearing problems and their management, supported by good quality written information. 19 
5.
Whether or not a baby with Down syndrome has passed a neonatal screen all should have full audiological assessment between age 6 and 10 months. This should include measurement of auditory thresholds, impedance testing and otoscopy. 10, 19, 21 To ensure inclusion of the child with Down's syndrome participation in existing child health hearing surveillance programmes should be encouraged.
6.
Therefore by 10 months it should have been established whether or not a child with Down syndrome has any degree of permanent hearing loss with or without OME. A clear management plan must have been agreed with the parents and intervention instigated where necessary.
7.
In the second year (usually around 18 months) all children with Down syndromewhatever their previous hearing status -should have further audiological review carried out in a manner appropriate for a child with learning disabilities. This should include assessment of auditory thresholds, impedance testing and otoscopy. This should be repeated at least yearly until age 5 and thereafter 2 yearly for life. More frequent testing will be necessary if problems exist.
8.
Transition of care from paediatric to adult services should involve direct transfer of care to a named person.
9.
At all ages people with Down's syndrome have narrow ear canals, which predispose to accumulation of wax. 5 This may affect impedance testing and hearing. Early management to clear wax would be desirable to remove any further impact on hearing loss.
10. Most people with Down syndrome are able to respond to standard tests -e.g. distraction; speech discrimination; pure tone audiometry (play or standard); and visual reinforcement audiometry. These tests must be performed by professionals trained in audiology with experience in working with people with learning disabilities. Threshold measurement tests appropriate to developmental age must be used. 7, 21 11. Because of increased incidence of sensorineural as well as conductive loss the frequency range tested should include 8000Hz whenever feasible as failure at this level may be an early warning of impending high frequency sensorineural deafness. 14. At all ages particular attention should be paid to the treatment of suppurative nasal and ear conditions. 4, 20 15. In adults with the syndrome hearing assessment is essential in the differential diagnosis of depression and dementia.
3
BASIC MEDICAL SURVEILLANCE ESSENTIALS
FOR PEOPLE WITH DOWN SYNDROME.
CERVICAL SPINE INSTABILITY
1. People with Down syndrome have a small risk for acute or chronic neurological problems caused by cervical spine instability.
1,2
2. Currently there is no screening procedure, which can predict those at risk. In particular cervical spine x-rays in children have no predictive validity for subsequent acute dislocation/ subluxation at the atlantoaxial joint. [3] [4] [5] [6] [7] 3. Children with Down syndrome should not be barred from sporting activities because there is no evidence that participation in sports increases the risk of cervical spine injury any more than for the general population. 6, 8 4. Although the risk of injury is small, if any child or adult with Down syndrome needs an anaesthetic, the anaesthetist and recovery room staff must always be reminded of the diagnosis, so that appropriate care can be taken to avoid cervical injury, whilst manipulating the head and neck in the unconscious subject. 6. If a person with Down syndrome develops pain behind the ear or elsewhere in the neck, abnormal head posture, torticollis, deterioration of gait, manipulative skills, or bowel and /or bladder control they should be referred immediately to an appropriate specialist (usually a neurologist or a spinal orthopaedic surgeon). 
DOWN'S SYNDROME SURVEILLANCE GUIDELINES
Background notes (As service delivery varies in different countries some minor adjustments to the guidelines have been made for Ireland and these appear in italics)
People with Down syndrome do not have unique medical problems, which differ from the general population. However some medical conditions are heavily over represented among those with the syndrome. Most of these are treatable disorders, which if undiagnosed, impose an additional but preventable burden of secondary handicap.
These surveillance guidelines have been developed on the basis of available evidence by a group of clinicians with a special interest in Down syndrome. They are updated as new research and audit evidence becomes available. The overall aim is to help ensure equitable provision of basic essential medical surveillance for all children with Down's syndrome in the UK and in the Republic of Ireland. The Royal College of Paediatrics and Child Health has been supportive of the venture and we have had guidance from the Centre for Evidence Based Child Health.
A set of background notes is being developed which cover the evidence on which the guidelines are based. Currently these are completed for the cardiac and hearing sections and are available electronically via jendennis@dsmig.org.uk
The guidelines are not a blueprint for Gold Star services. Their purpose is to set out a minimum safe standard of basic medical surveillance which we consider essential for all those with the syndrome. This we consider to be the identification of cardiac disease, thyroid disorder, hearing impairment and ophthalmic problems and the appropriate monitoring of growth. We have also included information which we hope will increase understanding of the complex issues surrounding cervical spine instability. We are currently producing clinical awareness notes covering other conditions which are over represented in the syndrome. In parallel with the guidelines we have produced UK/Ireland Down's syndrome specific growth charts and a special insert for UK Personal Child Health Record (The Red Book) for children born with Down's syndrome. 
